Related references
Note: Only part of the references are listed.A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression
Mohamed A. Kamal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A pharma perspective on the systems medicine and pharmacology of inflammation
Julio Lahoz-Beneytez et al.
MATHEMATICAL BIOSCIENCES (2015)
Modeling Influenza Virus Infection: A Roadmap for Influenza Research
Alessandro Boianelli et al.
VIRUSES-BASEL (2015)
The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice
Akitaka Tanaka et al.
ANTIVIRAL THERAPY (2015)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Viral kinetic modeling: state of the art
Laetitia Canini et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Effects of Aging on Influenza Virus Infection Dynamics
Esteban A. Hernandez-Vargas et al.
JOURNAL OF VIROLOGY (2014)
Antiviral combinations for severe influenza
Jake Dunning et al.
LANCET INFECTIOUS DISEASES (2014)
The co-pathogenesis of influenza viruses with bacteria in the lung
Jonathan A. McCullers
NATURE REVIEWS MICROBIOLOGY (2014)
Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study
Laetitia Canini et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Model-based drug discovery: implementation and impact
Sandra A. G. Visser et al.
DRUG DISCOVERY TODAY (2013)
Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients
Stella G. Muthuri et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response
Hana M. Dobrovolny et al.
PLOS ONE (2013)
Kinetics of Coinfection with Influenza A Virus and Streptococcus pneumoniae
Amber M. Smith et al.
PLOS PATHOGENS (2013)
Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1) pdm09
Janice K. Louie et al.
CLINICAL INFECTIOUS DISEASES (2012)
Type I Interferon Induction during Influenza Virus Infection Increases Susceptibility to Secondary Streptococcus pneumoniae Infection by Negative Regulation of γδ T Cells
Wenjing Li et al.
JOURNAL OF VIROLOGY (2012)
Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses
Kasia A. Pawelek et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead
Catherine A. A. Beauchemin et al.
BMC PUBLIC HEALTH (2011)
Cluster of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infections on a Hospital Ward among Immunocompromised Patients-North Carolina, 2009
Luke F. Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Structural Basis for Streptococcus pneumoniae NanA Inhibition by Influenza Antivirals Zanamivir and Oseltamivir Carboxylate
Heinz Gut et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study
Hana M. Dobrovolny et al.
JOURNAL OF THEORETICAL BIOLOGY (2011)
Population Modeling of Influenza A/H1N1 Virus Kinetics and Symptom Dynamics
Laetitia Canini et al.
JOURNAL OF VIROLOGY (2011)
Lethal Synergism of 2009 Pandemic H1N1 Influenza Virus and Streptococcus pneumoniae Coinfection Is Associated with Loss of Murine Lung Repair Responses
John C. Kash et al.
MBIO (2011)
H275Y Mutant Pandemic (H1N1) 2009 Virus in Immunocompromised Patients
Christian Renaud et al.
EMERGING INFECTIOUS DISEASES (2011)
Influenza Infection Leads to Increased Susceptibility to Subsequent Bacterial Superinfection by Impairing NK Cell Responses in the Lung
Cherrie-Lee Small et al.
JOURNAL OF IMMUNOLOGY (2010)
Competitive Fitness of Oseltamivir-Sensitive and -Resistant Highly Pathogenic H5N1 Influenza Viruses in a Ferret Model
Elena A. Govorkova et al.
JOURNAL OF VIROLOGY (2010)
Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected with Influenza A Virus
Hongyu Miao et al.
JOURNAL OF VIROLOGY (2010)
MODELING THE INTERACTION OF CYTOTOXIC T LYMPHOCYTES AND INFLUENZA VIRUS INFECTED EPITHELIAL CELLS
Abdessamad Tridane et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2010)
Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers
Y. Wattanagoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Arash Shahangian et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Treatment with Protein Synthesis Inhibitors Improves Outcomes of Secondary Bacterial Pneumonia after Influenza
Asa Karlstrom et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Sialic Acid: A Preventable Signal for Pneumococcal Biofilm Formation, Colonization, and Invasion of the Host
Claudia Trappetti et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Simulation and Prediction of the Adaptive Immune Response to Influenza A Virus Infection
Ha Youn Lee et al.
JOURNAL OF VIROLOGY (2009)
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008
Tiffany G. Sheu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Population pharmacokinetics of oseltamivir when coadministered with probenecid
Craig R. Rayner et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness
David M. Morens et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Neuraminidase inhibitor resistance in influenza: Assessing the danger of its generation and spread
Andreas Handel et al.
PLOS COMPUTATIONAL BIOLOGY (2007)
A dynamical model of human immune response to influenza A virus infection
Baris Hancioglu et al.
JOURNAL OF THEORETICAL BIOLOGY (2007)
Kinetics of influenza A virus infection in humans
Prasith Baccam et al.
JOURNAL OF VIROLOGY (2006)
Insights into the interaction between influenza virus and pneumococcus
Jonathan A. McCullers
CLINICAL MICROBIOLOGY REVIEWS (2006)
Influenza pandemics of the 20th century
ED Kilbourne
EMERGING INFECTIOUS DISEASES (2006)
Drug therapy - Neuraminidase inhibitors for influenza
A Moscona
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza
JA McCullers
JOURNAL OF INFECTIOUS DISEASES (2004)
Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
AA Mangoni et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Early administration of oral oseltamivir increases the benefits of influenza treatment
FY Aoki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Lethal Synergism between influenza virus and Streptococcus pneumoniae:: Characterization of a mouse model and the role of platelet-activating factor receptor
JA McCullers et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Updating the accounts: global mortality of the 1918-1920 Spanish influenza pandemic
NPAS Johnson et al.
BULLETIN OF THE HISTORY OF MEDICINE (2002)
Perspectives on antiviral use during pandemic influenza
FG Hayden
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2001)
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants
LV Gubareva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Neuraminidase inhibitors: Zanamivir and oseltamivir
IR McNicholl et al.
ANNALS OF PHARMACOTHERAPY (2001)
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial
JJ Treanor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
